Literature DB >> 10781004

Identification of the adenylyl cyclase-activating 5-hydroxytryptamine receptor subtypes expressed in the rat submandibular gland.

D M Bourdon1, J M Camden, L A Landon, F O Levy, J T Turner.   

Abstract

1. Serotonin (5-hydroxytryptamine, 5-HT) has been shown to increase cyclic AMP production in dispersed cell aggregates from the major salivary glands of the rat. The goal of the present study was to identify the 5-HT receptor subtypes that mediate these effects in rat submandibular glands (SMG). 2. Among the 5-HT receptor subtypes identified in the rat, 5-HT(4(a,b)), 5-HT(6) and 5-HT(7(a,b,c)) activate adenylyl cyclase (AC). We used subtype specific primers to screen rat SMG by reverse transcription-PCR. Results indicate the presence of mRNA for 5-HT(4(b)) and 5-HT(7(a)) but not for 5-HT(4(a)), 5-HT(6) and 5-HT(7(b,c)). 3. In dispersed SMG cells, 5-carboxyamidotryptamine (5-CT), a 5-HT(7) receptor agonist, stimulated cyclic AMP synthesis with higher potency (EC(50)=27+/-5 nM) but lower efficacy than 5-HT, suggesting a 5-HT(7) component and an additional component in the response to 5-HT. The 5-HT(7) contribution was further supported by antagonism of the 5-CT effect by metergoline, a 5-HT(7) antagonist, which exhibited an affinity (K(i)=50 nM) similar to that obtained at the cloned 5-HT(7) receptor. 4. In the presence of a maximally effective concentration of 5-CT, 5-HT produced an additional increase in cyclic AMP production that was inhibited by the 5-HT(4) receptor antagonist, GR113808, suggesting that the second component of cyclic AMP production is mediated by 5-HT(4) receptors. 5. These findings indicate the presence in rat SMG of both 5-HT(4(b)) and 5-HT(7(a)) receptors positively coupled to AC.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10781004      PMCID: PMC1572050          DOI: 10.1038/sj.bjp.0703303

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

Review 1.  Classification and nomenclature of 5-HT receptors: a comment on current issues.

Authors:  D Hoyer; G R Martin
Journal:  Behav Brain Res       Date:  1996       Impact factor: 3.332

2.  Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation.

Authors:  M Ruat; E Traiffort; R Leurs; J Tardivel-Lacombe; J Diaz; J M Arrang; J C Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

Review 3.  Serotonin receptors: subtypes, functional responses and therapeutic relevance.

Authors:  P R Saxena
Journal:  Pharmacol Ther       Date:  1995-05       Impact factor: 12.310

Review 4.  New players in the 5-HT receptor field: genes and knockouts.

Authors:  J J Lucas; R Hen
Journal:  Trends Pharmacol Sci       Date:  1995-07       Impact factor: 14.819

Review 5.  Molecular biology of 5-HT receptors.

Authors:  F G Boess; I L Martin
Journal:  Neuropharmacology       Date:  1994 Mar-Apr       Impact factor: 5.250

6.  A regulatory role in mammalian salivary glands for 5-hydroxytryptamine receptors coupled to increased cyclic AMP production.

Authors:  J T Turner; D M Sullivan; I Rovira; J M Camden
Journal:  J Dent Res       Date:  1996-03       Impact factor: 6.116

7.  Inhibition by 5-HT7 receptor stimulation of GABAA receptor-activated current in cultured rat suprachiasmatic neurones.

Authors:  F Kawahara; H Saito; H Katsuki
Journal:  J Physiol       Date:  1994-07-01       Impact factor: 5.182

8.  Development of a radioligand binding assay for 5-HT4 receptors in guinea-pig and rat brain.

Authors:  C J Grossman; G J Kilpatrick; K T Bunce
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

9.  Characterization of a postjunctional 5-HT receptor mediating relaxation of guinea-pig isolated ileum.

Authors:  D Carter; M Champney; B Hwang; R M Eglen
Journal:  Eur J Pharmacol       Date:  1995-07-14       Impact factor: 4.432

10.  The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants.

Authors:  C Gerald; N Adham; H T Kao; M A Olsen; T M Laz; L E Schechter; J A Bard; P J Vaysse; P R Hartig; T A Branchek
Journal:  EMBO J       Date:  1995-06-15       Impact factor: 11.598

View more
  4 in total

Review 1.  Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders.

Authors:  Marcello Leopoldo; Enza Lacivita; Francesco Berardi; Roberto Perrone; Peter B Hedlund
Journal:  Pharmacol Ther       Date:  2010-10-20       Impact factor: 12.310

2.  Intraluminal volume homeostasis: A common sertonergic mechanism among diverse epithelia.

Authors:  Vaibhav P Pai; Aaron M Marshall
Journal:  Commun Integr Biol       Date:  2011-09-01

3.  A 5-HT7 heteroreceptor-mediated inhibition of [3H]serotonin release in raphe nuclei slices of the rat: evidence for a serotonergic-glutamatergic interaction.

Authors:  Laszlo G Harsing; Ibolya Prauda; Jozsef Barkoczy; Peter Matyus; Zsolt Juranyi
Journal:  Neurochem Res       Date:  2004-08       Impact factor: 3.996

4.  The pharmacology of the neurochemical transmission in the midbrain raphe nuclei of the rat.

Authors:  L G Harsing
Journal:  Curr Neuropharmacol       Date:  2006-10       Impact factor: 7.363

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.